glp 1 receptor agonist drug names GLP-1 Agonists—commonly used for weight loss and diabetes—are now being linked to serious eye health concerns, including an increased risk of a condition called NAION, which can cause irreversible blindness. With GLP-1 GLP-1s (Glucagon-Like Peptide-1 receptor agonists)

doi: 10.1074/jbc.274.7.4124

Glucagon-like Peptide 1-related Peptides Increase Nitric Oxide Effects to Reduce Platelet Activation

In clinical trials, which compared people randomly assigned to the active drug or a placebo, participants receiving semaglutide or tirzepatide lost 15% to 20% of their body weight on average

Although these drugs undergo rigorous testing for safety and efficacy before approval, long-term effects may not be fully known

However, when compounded medications are marketed broadly and sold directly to consumers, they may fall outside the scope of traditional pharmacy practice and into potential legal jeopardy

Prevention: Follow your provider prescribed titration schedule